This indeterminate diagnosis is called cystic fibrosis transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive, inconclusive diagnosis (CFSPID). This evidence concerns the gene CFTR and CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.